Subclinical GvHD in non-irradiated F1 hybrids: severe lymphoid-tissue GvHD causing prolonged immune dysfunction (Q84526786)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Subclinical GvHD in non-irradiated F1 hybrids: severe lymphoid-tissue GvHD causing prolonged immune dysfunction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

B Van Wijmeersch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

A Luyckx

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

X Sagaert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

B Verbinnen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

O Rutgeerts

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

C Lenaerts

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

T Tousseyn

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

B Dubois

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

M Waer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

A D Billiau

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

5 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

586-596

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20603621%20AND%20SRC:MED&resulttype=core&format=json

Graft-versus-host disease

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplan

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Haploidentical hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Revisiting graft-versus-host disease models of autoimmunity: new insights in immune regulatory processes

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

A mouse model of lymphocyte infusion-induced bone marrow failure

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Defective stromal cell function in a mouse model of infusion-induced bone marrow failure

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Transforming growth factor-beta inhibits lymphokine activated killer cytotoxicity of bone marrow cells: implications for the graft-versus-leukemia effect in irradiation allogeneic bone marrow chimeras

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemic effect without graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Transient expansion of Mac1+Ly6-G+Ly6-C+ early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras: possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a graft-versus-autoimmunity effect

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Regulation of immune responses by L-arginine metabolism

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Myeloid-derived suppressor cell role in tumor-related inflammation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Induced SHIP deficiency expands myeloid regulatory cells and abrogates graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Protection from lethal graft-vs.-host disease by donor stem cell repopulation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021

Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.162

7 January 2021